In the case of cell-based therapy of GBM, (γδ) T cells seem to be a suitable subset of T cells due to their capability to infiltrate tumor tissue and anti-tumor activity (perforin–granzyme-mediated, expression of IFN-γ and TNFα) [138]. The gene discussed is IFNG; the disease is neoplasm.